Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 12 of 23
Retropubic vs. Single-Incision Mid-Urethral Sling for Stress Urinary Incontinence
NCT03520114
Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices
NCT03746314
Supportive Programs for Supporting Optimal Recovery in Participants Undergoing Gynecological Surgery
NCT03681405
FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)
NCT03489993
Pediatric Primary Hypertension and the Renin-Angiotensin System (PHRAS)
NCT03310684
Efficacy of Lidocaine Gel Enema After Endoscopic Hemorrhoid Band Ligation for Relief of Post Procedural Pain
NCT03797703
Study of the Effects of HIRREM-SOP for Insomnia
NCT03607994
Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer
NCT03662074
Integrated Multidisciplinary Patient and Family Advance Care Planning Trial
NCT03609658
Anchorsure Versus Capio for Sacrospinous Ligament Fixation
NCT03565640
Identifying Novel Aging Targets for Treatment of Delirium
NCT03682874
Short-term Clinical Deterioration After Acute Pulmonary Embolism
NCT03915925
Chewed Versus Integral Pill of Ticagrelor
NCT03708588
Graft-first Versus Fistula-first in Older Patients With End-stage Kidney Disease
NCT03545113
Infiltration Effect on SUV
NCT03320564
Pain and Sensation After Regional Anesthesia - Pilot Study
NCT03623035
Developing and Validating Fertilit-e
NCT03599661
Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer Patients
NCT03740035
HIRREM for Stage 1 Primary Hypertension
NCT03479697
A Mobile Intervention to Reduce Pain and Improve Health (MORPH)
NCT03377634
Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors
NCT03185546
Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer
NCT03505671
Extended Release Local Anesthetic for Postsurgical Pain After Posterior Colporrhaphy and Perineorrhaphy
NCT03875664
Brain Networks and Mobility Function: B-NET
NCT03430427
Stepped-Care Telehealth for Distress in Cancer Survivors
NCT03060096
Influence of Contrast Injection Force on the Accuracy of Vessel Measurements in Cerebral Angiography
NCT03949023
Prepulse Inhibition in Youth Contact Sports Players
NCT04058184
Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis
NCT03559075
Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer
NCT03505736
Habitual Diet and Avocado Trial
NCT03528031
Weight Loss With Risedronate for Bone Health
NCT03411902
The Use Of Liposomal Bupivacaine For Pain Control
NCT03722927
Learning by Repetitive Viewing of Peer Modeling Patient Education Videos by Adults With Down Syndrome
NCT03551418
Pre-medication With Alfentanil vs Placebo During ECT
NCT03359395
Implementation of Smoking Cessation Within NCI Community Oncology Research Program (NCORP) Sites
NCT03291587
HIRREM Hot Flashes Study
NCT03512002
Systems Support Mapping in Guiding Self-Management in Stage I-III Colorectal Cancer Survivors
NCT03520283
Hidradenitis Suppurativa Mail Survey
NCT03572738
A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis
NCT03465696
RAVE: Radial Artery Vascular Complication and Resource Utilization
NCT03522077
Anxiety and Depression in Epilepsy: A Treatment Study
NCT03464383
Prehospital Translation of Chest Pain Tools
NCT03494556
MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer
NCT03461354
EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery
NCT03379376
Feasibility of Aromatherapy in an Awake Craniotomy Environment
NCT03328143
Docusate/Senna for the Treatment of Diabetic Gastroparesis
NCT03342157
Independent Weight Loss Maintenance for Communities With Arthritis in North Carolina: the I-CAN Clinical Trial
NCT03832296
Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
NCT03363659
Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer
NCT03374995
Targeting Obesity to Optimize Health in Cardiac Rehab (TOPCARE)
NCT03423238
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.